1 Comment

  1. Krymsun
    October 20, 2012 @ 1:10 am

    In Americans for Safe Access, et al, v. Drug Enforcement Administration, U.S. Court of Appeals for the District of Columbia Circuit, No. 11-1265, according to testimony from DEA attorney Lena Watkins, 15 studies pertaining to the medicinal value of marijuana which adhere to “specific federal quality” standards have been conducted, but “we don’t have the final results yet.”

    I have questions.
    What studies are these?
    Who is conducting them? Where?
    When were they begun?
    How long a study, when should each be completed?
    What are the preliminary results?

    Answers to these questions could reveal more deliberate ‘foot-dragging’ by the DEA, another delaying tactic to prevent cannabis from being rescheduled. I searched online for answers to these questions, without satisfaction.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.